Livent Corp.·4

Jan 8, 4:10 PM ET

Ponessa Sara 4

4 · Livent Corp. · Filed Jan 8, 2024

Insider Transaction Report

Form 4
Period: 2024-01-04
Ponessa Sara
VP, Gen. Counsel & Secretary
Transactions
  • Disposition to Issuer

    Common Stock

    2024-01-0448,3590 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-0435,7170 total
    Exercise: $20.35From: 2024-02-22Exp: 2031-02-22Common Stock (35,717 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-0412,2020 total
    Exercise: $23.33From: 2026-02-22Exp: 2033-02-22Common Stock (12,202 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-0411,5910 total
    Exercise: $21.01From: 2025-02-23Exp: 2032-02-23Common Stock (11,591 underlying)
Footnotes (2)
  • [F1]Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction..
  • [F2]Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.

Documents

1 file
  • 4
    dp204987_4-ponessa.xmlPrimary

    FORM 4